Vann Equity Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Vann Equity Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$221K	Buy	+5,585	New	+$200K	0.13%	159

Other funds holding TEVA

Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Vann Equity Management's TEVA Position: Q3 2026 in Review

Vann Equity Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 5,585 shares worth $221K. The stake represents 0.13% of the portfolio and ranks #159 among its holdings.

10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Vann Equity Management held 5,585 shares of Teva Pharmaceutical Industries Limited worth $221K as of Q3 2026.
Teva Pharmaceutical Industries Limited was a new Vann Equity Management position in Q3 2026.
Teva Pharmaceutical Industries Limited made up 0.13% of Vann Equity Management's portfolio in Q3 2026, its #159 holding.
10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Vann Equity Management's 13F filing for Q3 2026, filed 8 Oct 2026.